EDGAR Filing Documents for 0001723128-19-000023

Form 8-K - Current report:

SEC Accession No. 0001723128-19-000023

Filing Date

2019-02-28

Accepted

2019-02-28 08:02:35

Documents

Period of Report

2019-02-28

Items

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	amrxform8-k3x1x19.htm	8-K	25892
2	EXHIBIT 99.1	amrxexhibit991pressrelease.htm	EX-99.1	1523335
3	LOGO	exhibit991892018image1a01.jpg	GRAPHIC	10129
	Complete submission text file	0001723128-19-000023.txt		1564500

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807

Business Address (908) 947-3120

Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 19640502
SIC: 2834 Pharmaceutical Preparations